A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)
RecruitingNCT05583942Phase: NAStarted 2022-09-19
Summary
Children with steroid resistant nephrotic syndrome (SRNS) are exposed to prolonged courses of immunosuppressant medications. Given the adverse side effect profiles and variable efficacy of these medic
Eligibility
Sex
ALL
Min Age
3 Years
Max Age
17 Years
Locations
Cohen Children's Medical CenterNew Hyde Park, New York, United States
Children's Hospital of PhiladelphiaPhiladelphia, Pennsylvania, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05583942